The Soothing Study

Currently Recruiting

3 Dec to 7 Dec 2025

Up to $7,400

The investigational treatment is being developed as a potential future therapy for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). This is the first step in evaluating the treatment’s safety and how it behaves in the body before testing its effectiveness in patients with these conditions. 

Apply now Speak with us

Join our clinical trial

The investigational treatment is being developed as a potential future therapy for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). This is the first step in evaluating the treatment’s safety and how it behaves in the body before testing its effectiveness in patients with these conditions. 

Why participate?

As a participant, you’ll receive the study medication and undergo assessments to monitor how your body responds. Your involvement will provide essential data that can help guide future research. 

  • Contribute to scientific research that may support the development of future treatment options. 
  • Help researchers understand how the investigational drug is absorbed and processed in the body.

Trial details

Study duration

4 nights stay, 9 follow-up visits

Study medication

Administered via subcutaneous (SC) or intravenous (IV) infusion.

Ethics

This is a first-in-human (FIH) study, meaning it is the first time this investigational treatment is being evaluated in humans. This clinical trial has been carefully designed to minimize risks for participants. Prior to participation, you will be provided with detailed information about the trial, its risks, and our mitigation strategies. You will also have an appointment with one of our doctors, who will be happy to answer any questions you may have. 

Additional eligibility

  • Females: postmenopausal, surgically sterile, or using two effective birth control methods (condom plus hormonal birth control, non-hormonal IUD, tubes tied, or partner with vasectomy). 
  • Males: use two effective birth control methods (condom plus one of the methods listed above) and no sperm donation.
  • Body weight ≥50 kg. 

Are you a match?

Age

18 - 55 years old

Remuneration

Up to $7,400 *with screening reimbursement. Please see T&Cs.

Gender

Male or Female (Post-menopausal)

BMI

BMI 18 - 32 kg/m2

Commitment

4 nights, 9 clinic visits

Register Your Interest

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We regularly have studies that allow participants who are (social) smokers.

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Preferences

While longer studies generally have a higher reimbursement, there are also studies with multiple short stays that have high reimbursements.
Referral Information



Consent to Information Use and Future Contact